[Estrogen treatment and endometrial cancer].
D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004714:Endometrial Hyperplasia / Q000139:chemically induced / Q000473:pathology; D004717:Endometrium / Q000187:drug effects; D045166:Estradiol Congeners / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects; D010051:Ovarian Neoplasms / Q000139:chemically induced; D012313:RNA / Q000378:metabolism; D011960:Receptors, Estrogen / Q000187:drug effects; D012189:Retrospective Studies; D012306:Risk; D013268:Stimulation, Chemical; D013997:Time Factors; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology
D045166:Estradiol Congeners; D011960:Receptors, Estrogen; D012313:RNA; D004247:DNA
Lechenie éstrogenami i rak éndometriia.